This event will be held to introduce cutting edge technologies and seeds in the life science fields that originated from Japanese top-ranked academia including Kyoto University. This will be an excellent opportunity for US investors, VC or technology scouts from pharmaceutical companies to discover promising startups.

Form of Event

Showcase

Themes

Pharmaceuticals, Drug Discovery; Cell Therapy; Diagnostics; Regenerative Medicine;
Medical Device;

Date and Time

Mar 3, 2021, 6:00am-10:00am (JST)
Mar 2, 2021, 1:00pm-5:00pm (PST)

Target participants

-Investors, Venture capitalists, Angels
-Pharmaceutical companies, Medical device companies
-Entrepreneurs from UCSD, Kyoto university, and other academic institutions

Venue

Online (via Remo Conference)

Fee

Free of charge

Presenters & Schedule 　※in PST

1:00pmOpening remark

1:10pm iBody Inc. - Novel Approach for Therapeutic Development from Natural Human Antibodies

1:20pm Epsilon Molecular Engineering, Inc. - Innovation for cancer immunotherapy with VHH-Based NanoCapsule

1:30pm Braizon Therapeutics, Inc. - Innovative Drug Delivery for Better Brain Therapies

1:50pm Triple W - Wearable device for urinary incontinence that predicts when you need to go the bathroom

2:00pm Syrinx - We restore the voice again for the patients who have lost their ones!

2:10pm iCorNet Laboratory Inc. - We will make the paradigm shift in the treatment of advanced heart failure and lethal arrhythmia by patient-specific cardiac net

2:30pm aceRNA Technologies, co., ltd. - New Pharmaceutical modalities with RNA switch technology

2:40pm LUCA Science Inc. - Energy For Life: Enabling functional mitochondria as therapeutic agents

2:50pm PuREC Co. , Ltd. - Rapidly Expanding MSC: from single cell to 1012 in 12 weeks Networking Time

3:10pm Therabiopharma Inc. - Suppression of cytokine storm by novel curcumin derivative

3:20pm HiLung Inc. - Inspiring Cell Technologies with innovative iPS cell platform in respiratory disease

3:30pm SUDx-Biotec Corp. - Novel molecular diagnosis for COVID-19 to quantify infectious viruses

3:50pm FIMECS, Inc. - Drugging Undruggable Targets

4:00pm BTB Drug Development Research Center Co.,Ltd. - Opioid crisis no more - a strong, non-opioid, non-addictive painkiller

4:10pm Progenicyte Japan Co., Ltd. - Now is the time to move regenerative medicine from cells to drugs

4:30pm ReguGene Co., Ltd. - Overcoming refractory cancers by using gene switch technology

4:40pm KORTUC Inc. - Entirely new method of radiosensitizer to bring paradigm shift to cancer treatment

4:50pm MediGear International Corporation - A novel drug free and universal cancer therapy with nano-device

5:00pmClosing remark

5:10pmAdjourn (Networking till 7:00)

Sponsor

Graduate School of Medicine Kyoto University, Kyoto University Research Administration Office (KURA), Kyoto University Research Center San Diego (KURC-SD), and Institute for Advancement of Clinical and Translational Science (iACT) Kyoto University Hospital

Co-sponsor

Foundation for Biomedical Research and Innovation at Kobe (FBRI),
Japan External Trade Organization (JETRO)

Contact

info@kurcsd.com

Registration